Secondary immunodeficiency: medicines, malignancy and infection risk
An evidence-informed international clinical reference on secondary immunodeficiency, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
